Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

Direct Payment

$150,000.00

Functional analysis of protein tyrosine phosphatase non-receptor type 22 (PTPN22) and its autoimmune-associated R620W variant in rheumatoid arthritis.

FY 2010-11

Summary
Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1% of Canadians and ultimately resulting in lowered life expectancy. Enzymes called protein tyrosine phosphatases regulate cellular processes involved in inflammation as well as metabolism and cancer. Several studies have recently linked the gene protein tyrosine phosphatase non-receptor type 22 (PTPN22) to autoimmune disease; namely, a variant of this gene, W620, is strongly associated with susceptibility to rheumatoid arthritis. This is believed to be through the important regulation of T cells by PTPN22. Mice expressing the W620 variant as well as mice lacking the normal PTPN22 gene will be examined for arthritic disease and its role in disease progression will be determined. Additionally, these mice will be crossed with a well-known rheumatoid arthritis mouse model to monitor the effect of this gene on established disease.The prevalence of W620 in human rheumatoid arthritis underscores the importance of understanding the role of LYP in this disease in order to identify new treatment strategies.
Program
CIHR Fellowship
Location
California, United States of America
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
226520
Name
Doody Karen M
Region
California
Country
United States of America
Orgtype
Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Functional analysis of protein tyrosine phosphatase non-receptor type 22 (PTPN22) and its autoimmune-associated R620W variant in rheumatoid arthritis.
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Flow Cytometry; Protein Tyrosine Phosphatase; Ptpn22; Rheumatoid Arthritis; Skg Mouse Model; T Cell Selection
Abstract
Rheumatoid arthritis (RA) is a chronic autoimmune disease affecting approximately 1% of Canadians and ultimately resulting in lowered life expectancy. Enzymes called protein tyrosine phosphatases regulate cellular processes involved in inflammation as well as metabolism and cancer. Several studies have recently linked the gene protein tyrosine phosphatase non-receptor type 22 (PTPN22) to autoimmune disease; namely, a variant of this gene, W620, is strongly associated with susceptibility to rheumatoid arthritis. This is believed to be through the important regulation of T cells by PTPN22. Mice expressing the W620 variant as well as mice lacking the normal PTPN22 gene will be examined for arthritic disease and its role in disease progression will be determined. Additionally, these mice will be crossed with a well-known rheumatoid arthritis mouse model to monitor the effect of this gene on established disease.The prevalence of W620 in human rheumatoid arthritis underscores the importance of understanding the role of LYP in this disease in order to identify new treatment strategies.
Competitiondate
201102
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Doody, Karen M
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~
Direct Payment - $150,000 Grant (2010-11) | Canada Spends